(LXS) LANXESS Aktiengesellschaft - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE0005470405
LXS: Chemicals, Additives, Intermediates, Flavors, Fragrances, Pigments
LANXESS Aktiengesellschaft, a global leader in specialty chemicals, operates with a rich history dating back to 1863. Headquartered in Cologne, Germany, the company was spun off from Bayer in 2004, emerging as an independent entity with a strong focus on innovation and sustainability. Listed on the XETRA exchange under the ticker LXS, LANXESS is structured into three core segments: Consumer Protection, Specialty Additives, and Advanced Intermediates, each catering to diverse industrial needs.
The Consumer Protection segment excels in material protection products, including water purification technologies and disinfectants, crucial for public health. Specialty Additives provides solutions for industries like automotive and electronics, enhancing product performance. Advanced Intermediates focuses on chemicals essential for agriculture and manufacturing, underscoring LANXESSs role in global supply chains.
With a market capitalization of 2289.04M EUR, LANXESS offers attractive valuations, reflected in its P/B ratio of 0.50. Its forward P/E of 14.58 indicates growth potential, aligning with its strategic focus on ESG practices and innovation. This positioning makes LANXESS a compelling option for investors seeking exposure to specialty chemicals with a strong emphasis on sustainability and global market presence.
Additional Sources for LXS Stock
LXS Stock Overview
| Market Cap in USD | 2,703m |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| GiC Sub-Industry | Specialty Chemicals |
| IPO / Inception |
LXS Stock Ratings
| Growth 5y | -28.3% |
| Fundamental | -27.9% |
| Dividend | 6.42% |
| Rel. Strength | 6.92 |
| Analysts | - |
| Fair Price Momentum | 26.02 EUR |
| Fair Price DCF | 43.89 EUR |
LXS Dividends
| Dividend Yield 12m | 0.76% |
| Yield on Cost 5y | 0.57% |
| Annual Growth 5y | -36.25% |
| Payout Consistency | 88.9% |
LXS Growth Ratios
| Growth Correlation 3m | 79.8% |
| Growth Correlation 12m | 37.3% |
| Growth Correlation 5y | -83.3% |
| CAGR 5y | -4.92% |
| CAGR/Max DD 5y | -0.07 |
| Sharpe Ratio 12m | -0.75 |
| Alpha | -13.94 |
| Beta | 1.645 |
| Volatility | 47.39% |
| Current Volume | 175.1k |
| Average Volume 20d | 488k |
As of April 03, 2025, the stock is trading at EUR 27.04 with a total of 175,059 shares traded.
Over the past week, the price has changed by -10.85%, over one month by -7.56%, over three months by +14.53% and over the past year by +2.71%.
Probably not. Based on ValueRay Fundamental Analyses, LANXESS Aktiengesellschaft (XETRA:LXS) is currently (April 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -27.89 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LXS as of April 2025 is 26.02. This means that LXS is currently overvalued and has a potential downside of -3.77%.
LANXESS Aktiengesellschaft has no consensus analysts rating.
According to ValueRays Forecast Model, LXS LANXESS Aktiengesellschaft will be worth about 28.6 in April 2026. The stock is currently trading at 27.04. This means that the stock has a potential upside of +5.81%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 30.3 | 12.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 28.6 | 5.8% |